Sharon Barber-Lui Acquires 65,250 Shares of PureTech Health (LON:PRTC) Stock

Key Points

• Sharon Barber-Lui, an insider at PureTech Health, purchased 65,250 shares of the company's stock at an average price of GBX 124 per share, totaling £80,910.
• PureTech Health's stock opened at GBX 128 after a 2.1% increase in value.
• The company operates in the clinical-stage biopharma sector, focusing on developing treatments for diseases linked to nervous, gastrointestinal, and immune system dysfunctions.

PureTech Health plc (LON:PRTC - ) insider Sharon Barber-Lui acquired 65,250 shares of the firm's stock in a transaction dated Tuesday, September 23rd. The shares were acquired at an average price of GBX 124 per share, for a total transaction of £80,910.

PureTech Health Trading Up 2.1%

LON PRTC opened at GBX 128 on Wednesday. The company has a market cap of £309.36 million, a P/E ratio of 752.94 and a beta of 1.02. PureTech Health plc has a 12 month low of GBX 100.40 and a 12 month high of GBX 178. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51. The company has a 50-day moving average of GBX 129.15 and a 200-day moving average of GBX 129.62.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.